David Hornigold

Head of Metabolism Bioscience (Interim) @AstraZeneca

Cambridge, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2025 — Present

Head of Metabolism Bioscience (Interim) @AstraZeneca

View department →

Cambridge, GB

EDUCATION

1994 — 1997

University of Leeds

BSc (Hons) Pharmacology, Pharmacology

1997 — 2001

University of Leicester

PhD, Molecular Pharmacology

ABOUT DAVID HORNIGOLD

Senior scientific leader with 20+ years of drug discovery and line management experience with a strong record of building high performing, collaborative multidisciplinary teams. Currently Interim Head of the Metabolism Bioscience Division within Cardiovascular Renal and Metabolism (CVRM) Research and Early Development at AstraZeneca, overseeing global in vitro and in vivo pharmacology groups across the UK, Sweden, and the US. Accountable for obesity, diabetes, MASH, and dyslipidaemia portfolio.Extensive expertise across pre clinical drug discovery, from target identification to clinical candidate nomination, early clinical development, regulatory filings, and business development evaluations. Proven success leading projects through key milestones and cultivating effective internal and external partnerships. Seeking opportunities to lead within an agile, collaborative organization to advance impactful science and business strategy in the metabolism space.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

David Hornigold — Head of Metabolism Bioscience (Interim) at AstraZeneca in Cambridge, GB | Unifers